Procept Biorobotics
PRCT
162 hedge funds and large institutions have $2.26B invested in Procept Biorobotics in 2024 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 59 increasing their positions, 47 reducing their positions, and 13 closing their positions.
138% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 13
26% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 47
18% more capital invested
Capital invested by funds: $1.92B → $2.26B (+$341M)
12% more funds holding
Funds holding: 145 → 162 (+17)
6% more call options, than puts
Call options by funds: $27.9M | Put options by funds: $26.5M
0.62% less ownership
Funds ownership: 90.75% → 90.13% (-0.62%)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair & Company
Chicago,
Illinois
|
+$20.5M |
| 2 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
+$20.4M |
| 3 |
Voloridge Investment Management
Jupiter,
Florida
|
+$10.8M |
| 4 |
PA
Perceptive Advisors
New York
|
+$10M |
| 5 |
Two Sigma Investments
New York
|
+$9.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$35.9M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$23.2M |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$13M |
| 4 |
FRA
Frank Rimerman Advisors
Palo Alto,
California
|
-$12.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$11.3M |
PRCT Hedge Fund Activity: Q1 2024 in Review
162 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Procept Biorobotics (PRCT) for Q1 2024, worth a combined $2.26B — up 18% from $1.92B a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new PRCT positions and 13 closed out — a net gain of 18 holders — while 59 added to existing stakes and 47 trimmed.
The largest buyer was William Blair & Company, opening a new position worth an estimated $20.5M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $35.9M.
- 162 institutional investors held Procept Biorobotics (PRCT) as of Q1 2024, up from 145 in Q4 2023.
- Funds reported $2.26B of Procept Biorobotics stock for Q1 2024, up 18% quarter-over-quarter.
- 31 funds opened new Procept Biorobotics positions in Q1 2024 and 13 closed out, a net change of +18 holders.
- The largest Procept Biorobotics buyer in Q1 2024 was William Blair & Company, an estimated $20.5M added.
- The largest Procept Biorobotics seller in Q1 2024 was T. Rowe Price Investment Management, an estimated $35.9M sold.
Based on aggregated 13F filings for Q1 2024.